Arbutus Biopharma (ABUS) Acquisitions (2015)
Arbutus Biopharma (ABUS) posted Acquisitions of $324000.0 for Q1 2015.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Acquisitions (2015) Analysis & Trends
Arbutus Biopharma has reported Acquisitions for 1 years, with the latest figure at $324000.0 in Q1 2015.
- Quarterly Acquisitions changed N/A year-over-year to $324000.0 in Q1 2015, while the trailing twelve-month figure through Dec 2015 was $324000.0 (changed N/A YoY) and the FY2015 annual result came in at $324000.0, changed N/A from the prior year.
- Acquisitions steadied at $324000.0 in Q1 2015 per ABUS's latest filing.
- Over five years, Acquisitions peaked at $324000.0 in Q1 2015 and troughed at $324000.0 in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Arbutus Biopharma | 1.02 Bn | 927.31 Mn | - | - |